1H-Pyrrolo[3,2-c]quinoline-8-carboxylicacid,2,3,3a,4,5,9b-hexahydro-1-[imino[(3-methyl-2-buten-1-yl)amino]methyl]-4-[3-[[imino[(3-methyl-2-buten-1-yl)amino]methyl]amino]propyl]-,(2E)-4-[(aminoiminomethyl)amino]-2-methyl-2-buten-1-yl ester, (3aS,4S,9bS)- [

CAS No: 164178-52-3

pyrrolo,quinoline,carboxylicacid,hexahydro,imino,methyl,buten,amino,propyl,aminoiminomethyl,ester

16421-56-0 Spiro[furan-2(3H),7'-[2,5]methano[7H]oxireno[3,4]cyclopent[1,2-d]oxepin]-4-carboxylicacid,1'a,1'b,2',3',5',6',6'a,7'a-octahydro-1'b,6'-dihydroxy-5,6'a-dimethyl-8'-(1-methylethenyl)-3'-oxo-(9CI)

164203-85-4 SchisantherinP

16421-04-8 sodium [3-[4-(benzoylamino)-2,5-dimethoxyphenyl]-1-methyl-2-triazenyl]acetate

164228-15-3 4-Pentenoic acid, 2-fluoro-2-propyl-, ethyl ester

164200-11-7 (1S,6S)-6-Methylbicyclo[4.1.0]hept-2-ene-1,2-dicarbaldehyde

164204-79-9 5-Cyclohexene-1,2,3,4-tetrol,2-[(benzoyloxy)methyl]-, 3-acetate 4-benzoate, [1S-(1a,2b,3b,4a)]-

164205-99-6 male-specific lethal-3 protein

164230-54-0 JubanineD

164213-21-2 BICYCLO[3.2.1]OCTANE-1-CARBONITRILE,6-VINYL-2-OXO-,ENDO-

1642-30-4 2,2'-(1,1,2,2,3,3-hexafluoropropane-1,3-diyl)bis(1H-benzimidazole)

164223-42-1 Isoxazolo[4,5-c]pyridin-4(5H)-one,6,7-dihydro-3-methyl-

16418-23-8 3,1,5-Benzoxadiazepine, 2,4-diphenyl-

16422-07-4 H-ALA-ALA-GLY-OH

164204-63-1 2,8:10,18-Dimethano-8H,14H,18H-pyrano[2,3-h']benzo[1,2-d:3,4-d']bis[1,3]benzodioxocin-5,7,13,15,19,21,22-heptol,2,10,16-tris(3,4-dihydroxyphenyl)-15,16-dihydro-, [2S-(2a,8a,10a,15a,16b,18a,21R*,22S*)]-

16421-52-6 CH2N4O

164204-61-9 Indeno[1',2':2,3]indeno[5,6-b]furan-4,7,9-triol,3-(3,5-dihydroxyphenyl)-2,3,5,5a,10,10a-hexahydro-2,5,10-tris(4-hydroxyphenyl)-,[2S-(2a,3b,5b,5ab,10b,10ab)]-

164228-80-2 L-Cysteine,N-acetyl-S-[1,3,3,3-tetrafluoro-2-(fluoromethoxy)-1-propenyl]-

16422-79-0 Phosphonitrile chloride, trimer

164204-46-0 (3S)-3-(3-methylbutoxy)-3-(naphthalen-1-yloxy)-N-(propan-2-yl)propan-1-amine

164223-43-2 ISOXAZOLO[4,5-C]PYRIDIN-4(5H)-ONE,3-METHYL-